Xencor Appoints Bart Cornelissen as Chief Financial Officer

The appointment of Alumnus Bart Cornelissen MScBA to to senior vice president and chief financial officer of Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases.

Read the article: https://www.businesswire.com/news/home/20240409569704/en/

Participants

  • Bart Cornelissen
    Role: Alumni
    Reference type: Featured

Media Outlets

  • Business Wire (Online)